Phase III
A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of IMVT-1402 in Patients With Mild to Severe Generalized Myasthenia Gravis
- Study HIC#:2000040089
- Last Updated:03/24/2026
Contact Us
For more information about this study, including how to volunteer, contact:
Bailey Sheldon
- Phone Number: 1-203-737-7095
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
